Please use this identifier to cite or link to this item:
Title: V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a.
Authors: Carragher, Linda A. S.
Snell, Kimberley R.
Giblett, Susan M.
Aldridge, Victoria S. S.
Patel, Bipin
Cook, S. J.
Winton, D. J.
Marais, R.
Pritchard, Catrin A.
First Published: 13-Oct-2010
Publisher: Wiley Open Access with European Molecular Biology Organization (EMBO) with Wiley-VCH Verlag, EMBO Press
Citation: EMBO Molecular Medicine, 2010, 2 (11), pp. 458-471
Abstract: The majority of human colorectal cancers (CRCs) are initiated by mutations arising in the adenomatous polyposis coli (APC) tumour suppressor gene. However, a new class of non-APC mutated CRCs has been defined that have a serrated histopathology and carry the (V600E)BRAF oncogene. Here we have investigated the pathogenesis of serrated CRCs by expressing (V600E)Braf in the proliferative cells of the mouse gastrointestinal tract. We show that the oncogene drives an initial burst of Mek-dependent proliferation, leading to the formation of hyperplastic crypts. This is associated with β-catenin nuclear localization by a mechanism involving Mapk/Erk kinase (Mek)-dependent, Akt-independent phosphorylation of Gsk3β. However, hyperplastic crypts remain dormant for prolonged periods due to the induction of crypt senescence accompanied by upregulation of senescence-associated β-galactosidase and p16(Ink4a). We show that tumour progression is associated with down-regulation of p16(Ink4a) through enhanced CpG methylation of exon 1 and knockout of Cdkn2a confirms this gene is a barrier to tumour progression. Our studies identify (V600E)BRAF as an early genetic driver mutation in serrated CRCs and indicate that, unlike APC-mutated cancers, this subtype arises by the bypassing of a (V600E)Braf driven oncogene-induced senescence programme.
DOI Link: 10.1002/emmm.201000099
ISSN: 1757-4676
eISSN: 1757-4684
Type: Journal Article
Rights: Archived with reference to SHERPA/RoMEO and publisher website. Copyright 2010 EMBO Molecular Medicine "For articles accepted prior to 14 August 2012, permission is not required for academic re-use, however commercial re-use still requires permission."
Appears in Collections:Published Articles, Dept. of Biochemistry

Files in This Item:
File Description SizeFormat 
458.full.pdfPublisher Version1.51 MBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.